Advertisement
Patients perceive that physicians who communicate face-to-face without a computer have more compassion

Patients Prefer Face-to-Face Communication, No Computer

0
Seventy-two percent of patients with advanced cancer prefer face-to-face communication
Since 1984

Gastric Cancer Incidence Down, Survival Up

0
Incidence declined between 1984 and 2014, but long-term survival rates are still low
The 70-gene signature assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay

70-Gene Signature Impacts Treatment Decisions in Breast CA

0
70-GS linked to change in treatment decisions for intermediate-risk patients based on 21-gene assay
For patients with head and neck cancer

Multidisciplinary Model Cuts Treatment Delay in Head, Neck CA

0
Fewer instances of delay >30 days from referral to treatment initiation in multidisciplinary clinic
For patients with stage I non-small-cell lung cancer

Treatment for Stage I NSCLC Patients Up From 2000 to 2010

0
Improved survival for non-small-cell lung cancer patients, driven by better survival in treated patients
The demand for fertility preservation is increasing

Demand for Fertility Preservation Increasing for Women

0
Oocyte cryopreservation by vitrification provides highest yield, suitable when cancer tx can be delayed
Receipt of gifts from pharmaceutical companies is associated with more prescriptions per patient and more costly prescriptions

Gifts From Pharma Companies Influence Prescribing Behavior

0
Clinicians who receive gifts write more prescriptions per patient, more costly and branded prescriptions
For patients with oropharyngeal squamous cell carcinoma

Better Outcomes With Transoroal Robotic Surgery Alone in OPSCC

0
Significantly quicker improvement in postoperative dysphagia in oropharyngeal cancer TORS-only group
For older women with cataract

Cataract Surgery Associated With Reduced Mortality in Women

0
Lower all-cause, vascular-, cancer-, accidental-, neurologic-, pulmonary-specific mortality
Higher HER3 expression is associated with improved survival with the addition of panitumumab treatment for patients with RAS wild-type advanced colorectal cancer

HER3 Linked to Improved Survival With Panitumumab

0
Addition of panitumumab to irinotecan tied to improved survival in RAS wt advanced colorectal CA